The aim of this study was to determine the role of KIR+ CD8+ T cells in cancer immune surveillance by analyzing the frequency of these cells in peripheral blood of patients with different types of solid cancers at diagnosis, and their association with specific KIR/HLA-ligand interactions and patient survival. Here, KIR3DL1 is linked to cancer.